This site is intended for health professionals only

Published on 1 August 2007

Share this story:

RELATED ARTICLES
Low-carbon COPD triple combination inhaler gains world-first approval
Nirmatrelvir plus ritonavir withdrawn by NICE for some at-risk groups
Exemption clause for pharmacy professionals added to assisted dying bill
Independent prescribing on the rise as a third of GB pharmacists now qualified
Concerns over emerging bacterial resistance to ceftazidime/avibactam

Step forward for Tamiflu

teaser

↓Article continues below this sponsored advert↓
↑Advertisement↑

Roche has received a positive opinion in Europe from the Committee of Human Medicinal Products (CHMP) recommending marketing authorisation for Tamiflu






Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
Share this story:

RELATED ARTICLES
Coronary angioplasty improves cardiac arrest survival
Undertaking lifelong endurance exercise linked to unfavourable coronary plaque composition
Novel glioblastoma therapy holds promise
University ties with firms “weaker”
New and expanded routes for pharmacist training detailed in long-awaited NHS England workforce plan
FOLLOW US

IMPORTANT LINKS

MORE FROM COGORA

© Cogora 2025
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x